Guardant Health acquires MetaSight amid positive 2026 financial outlook
This acquisition comes as analysts remain intrigued by the company’s long-term growth prospects.
Therapy Area
UK’s NICE greenlights Abbott’s CardioMEMS heart failure sensor
Pulse Biosciences and MD Anderson to study nPulse for thyroid cancer
Roche gains CE Mark for bacterial vaginosis/candida vaginitis assay
Lunit seeks FDA clearance for breast cancer risk prediction model
Örebro University researchers develop new AI models for dementia
Cordance to advance ultrasound platform trial with new funding
Beacon and Takeda expand neurobiomarker discovery collaboration
